Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations

Y.Y. Janjigian, E.F. Smit, H.J.M. Groen, L. Horn, S. Gettinger, D.R. Camidge, G.J. Riely, B.S. Wang, Y. Fu, V.K. Chand, V.A. Miller, W. Pao

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1036-1045
JournalCancer discovery
Volume4
Issue number9
DOIs
Publication statusPublished - 2014

Cite this

Janjigian, Y.Y. ; Smit, E.F. ; Groen, H.J.M. ; Horn, L. ; Gettinger, S. ; Camidge, D.R. ; Riely, G.J. ; Wang, B.S. ; Fu, Y. ; Chand, V.K. ; Miller, V.A. ; Pao, W. / Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations. In: Cancer discovery. 2014 ; Vol. 4, No. 9. pp. 1036-1045.
@article{f540aab837bc47be821179bc79f7bf7f,
title = "Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations",
author = "Y.Y. Janjigian and E.F. Smit and H.J.M. Groen and L. Horn and S. Gettinger and D.R. Camidge and G.J. Riely and B.S. Wang and Y. Fu and V.K. Chand and V.A. Miller and W. Pao",
year = "2014",
doi = "10.1158/2159-8290.CD-14-0326",
language = "Undefined/Unknown",
volume = "4",
pages = "1036--1045",
journal = "Cancer discovery",
issn = "2159-8274",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

Janjigian, YY, Smit, EF, Groen, HJM, Horn, L, Gettinger, S, Camidge, DR, Riely, GJ, Wang, BS, Fu, Y, Chand, VK, Miller, VA & Pao, W 2014, 'Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations' Cancer discovery, vol. 4, no. 9, pp. 1036-1045. https://doi.org/10.1158/2159-8290.CD-14-0326

Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations. / Janjigian, Y.Y.; Smit, E.F.; Groen, H.J.M.; Horn, L.; Gettinger, S.; Camidge, D.R.; Riely, G.J.; Wang, B.S.; Fu, Y.; Chand, V.K.; Miller, V.A.; Pao, W.

In: Cancer discovery, Vol. 4, No. 9, 2014, p. 1036-1045.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations

AU - Janjigian, Y.Y.

AU - Smit, E.F.

AU - Groen, H.J.M.

AU - Horn, L.

AU - Gettinger, S.

AU - Camidge, D.R.

AU - Riely, G.J.

AU - Wang, B.S.

AU - Fu, Y.

AU - Chand, V.K.

AU - Miller, V.A.

AU - Pao, W.

PY - 2014

Y1 - 2014

U2 - 10.1158/2159-8290.CD-14-0326

DO - 10.1158/2159-8290.CD-14-0326

M3 - Article

VL - 4

SP - 1036

EP - 1045

JO - Cancer discovery

JF - Cancer discovery

SN - 2159-8274

IS - 9

ER -